Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Comparative evaluation of operating room terminal cleaning by two methods: Focused multivector ultraviolet (FMUV) versus manual-chemical disinfection.

Armellino D, Goldstein K, Thomas L, Walsh TJ, Petraitis V.

Am J Infect Control. 2019 Nov 30. pii: S0196-6553(19)30901-0. doi: 10.1016/j.ajic.2019.10.009. [Epub ahead of print]

PMID:
31796341
2.

Molecular Characterization of Uropathogenic Escherichia coli Reveals Emergence of Drug Resistant O15, O22 and O25 Serogroups.

Prakapaite R, Saab F, Planciuniene R, Petraitis V, Walsh TJ, Petraitiene R, Semoskaite R, Baneviciene R, Kalediene L, Kavaliauskas P.

Medicina (Kaunas). 2019 Nov 11;55(11). pii: E733. doi: 10.3390/medicina55110733.

3.

Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis.

Petraitis V, Petraitiene R, Valdez JM, Pyrgos V, Lizak MJ, Klaunberg BA, Kalasauskas D, Basevicius A, Bacher JD, Benjamin DK Jr, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01626-19. doi: 10.1128/AAC.01626-19. [Epub ahead of print]

PMID:
31591128
4.

Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma.

Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP.

J Fungi (Basel). 2019 Jul 4;5(3). pii: E57. doi: 10.3390/jof5030057. Review.

5.

Ceftolozane-Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance.

Petraitis V, Petraitiene R, Naing E, Aung T, Thi WP, Kavaliauskas P, Win Maung BB, Michel AO, Ricart Arbona RJ, DeRyke AC, Culshaw DL, Nicolau DP, Satlin MJ, Walsh TJ.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00344-19. doi: 10.1128/AAC.00344-19. Print 2019 Sep.

PMID:
31235620
6.

Assessing the Feasibility of a Focused Multivector Ultraviolet System Between Surgery Cases with a Parallel Protocol for Enhanced Disinfection Capabilities.

Armellino D, Walsh TJ, Petraitis V, Kowalski W.

Am J Infect Control. 2019 Aug;47(8):1006-1008. doi: 10.1016/j.ajic.2019.02.017. Epub 2019 Mar 21.

PMID:
30904373
7.

Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model.

Gamaletsou MN, Meletiadis J, Chatziioannou S, Panayiotides IG, Agadakos E, Katsimpoulas M, Kostomitsopoulos N, Petraitis V, Walsh TJ, Sipsas NV.

Med Mycol. 2019 Nov 1;57(8):1011-1017. doi: 10.1093/mmy/myz001.

PMID:
30753591
8.

Assessment of focused multivector ultraviolet disinfection withshadowless delivery using 5-point multisided sampling ofpatientcare equipment without manual-chemical disinfection.

Armellino D, Walsh TJ, Petraitis V, Kowalski W.

Am J Infect Control. 2019 Apr;47(4):409-414. doi: 10.1016/j.ajic.2018.09.019. Epub 2018 Nov 28.

PMID:
30502110
9.

Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits.

Petraitis V, Petraitiene R, Maung BBW, Khan F, Alisauskaite I, Olesky M, Newman J, Mutlib A, Niu X, Satlin M, Singh RS, Derendorf H, Walsh TJ.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00275-18. doi: 10.1128/AAC.00275-18. Print 2018 Sep.

10.

Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.

McCarthy MW, Moriyama B, Petraitiene R, Walsh TJ, Petraitis V.

Clin Pharmacokinet. 2018 Dec;57(12):1483-1491. doi: 10.1007/s40262-018-0673-2. Review.

PMID:
29725999
11.

Fungal Infections of the Central Nervous System in Children.

McCarthy MW, Kalasauskas D, Petraitis V, Petraitiene R, Walsh TJ.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e123-e133. doi: 10.1093/jpids/pix059. Review.

PMID:
28903523
12.

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Petraitis V, Petraitiene R, McCarthy MW, Kovanda LL, Zaw MH, Hussain K, Shaikh N, Maung BBW, Sekhon NK, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00305-17. doi: 10.1128/AAC.00305-17. Print 2017 Sep.

13.

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis.

Petraitis V, Petraitiene R, Hope WW, Walsh TJ.

Methods Mol Biol. 2017;1625:259-277. doi: 10.1007/978-1-4939-7104-6_18.

PMID:
28584996
14.

Combination therapy for the treatment of pulmonary mold infections.

McCarthy MW, Petraitis V, Walsh TJ.

Expert Rev Respir Med. 2017 Jun;11(6):481-489. doi: 10.1080/17476348.2017.1325322. Epub 2017 May 9. Review.

PMID:
28467730
15.

In vitro combination therapy with isavuconazole against Candida spp.

Katragkou A, McCarthy M, Meletiadis J, Hussain K, Moradi PW, Strauss GE, Myint KL, Zaw MH, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ, Petraitis V.

Med Mycol. 2017 Nov 1;55(8):859-868. doi: 10.1093/mmy/myx006.

PMID:
28204571
16.

Diagnosis, classification, and therapeutic interventions for sinopulmonary Aspergillosis.

McCarthy MW, Aguilar-Zapata D, Petraitis V, Walsh TJ.

Expert Rev Respir Med. 2017 Mar;11(3):229-238. doi: 10.1080/17476348.2017.1283986. Epub 2017 Jan 27. Review.

PMID:
28095078
17.

Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century.

Taj-Aldeen SJ, Gamaletsou MN, Rammaert B, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Henry M, Petraitis V, Moriyama B, Denning DW, Lortholary O, Walsh TJ; International Osteoarticular Mycoses Consortium.

Med Mycol. 2017 Oct 1;55(7):691-704. doi: 10.1093/mmy/myw136. Review.

18.

Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases.

Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Henry M, Petraitis V, Denning DW, Lortholary O, Walsh TJ; International Osteoarticular Mycoses Consortium.

Med Mycol. 2017 Apr 1;55(3):246-254. doi: 10.1093/mmy/myw077.

19.

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints.

Kovanda LL, Petraitiene R, Petraitis V, Walsh TJ, Desai A, Bonate P, Hope WW.

J Antimicrob Chemother. 2016 Jul;71(7):1885-91. doi: 10.1093/jac/dkw098. Epub 2016 Apr 15.

20.

Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Petraitis V, Petraitiene R, Moradi PW, Strauss GE, Katragkou A, Kovanda LL, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2718-26. doi: 10.1128/AAC.02665-15. Print 2016 May.

21.

Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review.

Taj-Aldeen SJ, Rammaert B, Gamaletsou M, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Miller AO, Petraitis V, Walsh TJ, Lortholary O; International Osteoarticular Mycoses Consortium.

Medicine (Baltimore). 2015 Dec;94(50):e2078. doi: 10.1097/MD.0000000000002078. Review.

22.

Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.

Petraitiene R, Petraitis V, Hope WW, Walsh TJ.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S643-51. doi: 10.1093/cid/civ817.

23.

The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.

Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S618-21. doi: 10.1093/cid/civ815.

PMID:
26567279
24.

Echinocandins: The Expanding Antifungal Armamentarium.

Aguilar-Zapata D, Petraitiene R, Petraitis V.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S604-11. doi: 10.1093/cid/civ814. Review.

PMID:
26567277
25.

Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.

Petraitiene R, Petraitis V, Bacher JD, Finkelman MA, Walsh TJ.

Med Mycol. 2015 Aug;53(6):558-68. doi: 10.1093/mmy/myv034. Epub 2015 Jun 30.

PMID:
26129890
26.

Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.

Al-Nakeeb Z, Petraitis V, Goodwin J, Petraitiene R, Walsh TJ, Hope WW.

Antimicrob Agents Chemother. 2015 May;59(5):2735-45. doi: 10.1128/AAC.04723-14. Epub 2015 Feb 23.

27.

Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction.

Gu Z, Buelow DR, Petraitiene R, Petraitis V, Walsh TJ, Hayden RT.

Arch Pathol Lab Med. 2014 Nov;138(11):1474-80. doi: 10.5858/arpa.2013-0592-OA.

PMID:
25357108
28.

In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.

Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2015 Feb;70(2):470-8. doi: 10.1093/jac/dku374. Epub 2014 Oct 6.

29.

In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.

Katragkou A, McCarthy M, Meletiadis J, Petraitis V, Moradi PW, Strauss GE, Fouant MM, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ.

Antimicrob Agents Chemother. 2014 Nov;58(11):6934-7. doi: 10.1128/AAC.03261-14. Epub 2014 Aug 18.

30.

Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum.

Simitsopoulou M, Walsh TJ, Kyrpitzi D, Petraitis V, Kontoyiannis DP, Perlin DS, Roilides E.

Med Mycol. 2015 Feb 1;53(2):189-93. doi: 10.1093/mmy/myu034. Epub 2014 Jul 23.

PMID:
25056961
31.

Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response.

Krel M, Petraitis V, Petraitiene R, Jain MR, Zhao Y, Li H, Walsh TJ, Perlin DS.

Antimicrob Agents Chemother. 2014 Jun;58(6):3373-8. doi: 10.1128/AAC.02482-14. Epub 2014 Mar 31.

32.

Environmental monitoring for Aspergillus fumigatus in association with an immunosuppressed rabbit model of pulmonary aspergillosis.

Such KA, Petraitis V, Petraitiene R, Strauss GE, Moradi PW, Walsh TJ.

J Am Assoc Lab Anim Sci. 2013 Sep;52(5):541-4.

33.

Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.

Petraitis V, Petraitiene R, Antachopoulos C, Hughes JE, Cotton MP, Kasai M, Harrington S, Gamaletsou MN, Bacher JD, Kontoyiannis DP, Roilides E, Walsh TJ.

Med Mycol. 2013 Jan;51(1):72-82. doi: 10.3109/13693786.2012.690107. Epub 2012 Jun 11.

PMID:
22686246
34.

Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense.

Vethanayagam RR, Almyroudis NG, Grimm MJ, Lewandowski DC, Pham CT, Blackwell TS, Petraitiene R, Petraitis V, Walsh TJ, Urban CF, Segal BH.

PLoS One. 2011;6(12):e28149. doi: 10.1371/journal.pone.0028149. Epub 2011 Dec 7.

35.

Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.

Warn PA, Livermore J, Howard S, Felton TW, Sharp A, Gregson L, Goodwin J, Petraitiene R, Petraitis V, Cohen-Wolkowiez M, Walsh TJ, Benjamin DK Jr, Hope WW.

Antimicrob Agents Chemother. 2012 Feb;56(2):708-14. doi: 10.1128/AAC.05826-11. Epub 2011 Nov 28.

36.

Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.

Petraitiene R, Petraitis V, Witt JR 3rd, Durkin MM, Bacher JD, Wheat LJ, Walsh TJ.

J Clin Microbiol. 2011 Dec;49(12):4330-2. doi: 10.1128/JCM.05031-11. Epub 2011 Oct 5.

37.

Molecular detection and species-specific identification of medically important Aspergillus species by real-time PCR in experimental invasive pulmonary aspergillosis.

Walsh TJ, Wissel MC, Grantham KJ, Petraitiene R, Petraitis V, Kasai M, Francesconi A, Cotton MP, Hughes JE, Greene L, Bacher JD, Manna P, Salomoni M, Kleiboeker SB, Reddy SK.

J Clin Microbiol. 2011 Dec;49(12):4150-7. doi: 10.1128/JCM.00570-11. Epub 2011 Oct 5.

38.

The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.

Hope WW, Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2010 Nov;54(11):4879-86. doi: 10.1128/AAC.00673-10. Epub 2010 Aug 16.

39.

Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.

Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2009 Jun;53(6):2382-91. doi: 10.1128/AAC.00329-09. Epub 2009 Mar 23.

40.

Diagnostic imaging of experimental invasive pulmonary aspergillosis.

Walsh TJ, Petraitis V, Petraitiene R, Solomon J, Bacher JD, Greene L, Cotton M, Groll A, Roilides E, Avila N, Pyrgos V, Shoham S.

Med Mycol. 2009;47 Suppl 1:S138-45. doi: 10.1080/13693780802665879. Epub 2009 Feb 27. Review.

PMID:
19253145
41.

Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.

Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, Walsh TJ.

J Clin Microbiol. 2008 Nov;46(11):3690-702. doi: 10.1128/JCM.00917-08. Epub 2008 Sep 24.

42.

Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.

Petraitiene R, Petraitis V, Hope WW, Mickiene D, Kelaher AM, Murray HA, Mya-San C, Hughes JE, Cotton MP, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2008 Nov;52(11):4121-9. doi: 10.1128/AAC.00674-08. Epub 2008 Sep 8.

43.

Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR.

Francesconi A, Kasai M, Harrington SM, Beveridge MG, Petraitiene R, Petraitis V, Schaufele RL, Walsh TJ.

J Clin Microbiol. 2008 Jun;46(6):1978-84. doi: 10.1128/JCM.02246-07. Epub 2008 Mar 19.

44.

The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.

Hope WW, Mickiene D, Petraitis V, Petraitiene R, Kelaher AM, Hughes JE, Cotton MP, Bacher J, Keirns JJ, Buell D, Heresi G, Benjamin DK Jr, Groll AH, Drusano GL, Walsh TJ.

J Infect Dis. 2008 Jan 1;197(1):163-71. doi: 10.1086/524063.

45.

Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.

Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ.

J Infect Dis. 2007 Feb 1;195(3):455-66. Epub 2006 Dec 21.

PMID:
17205486
46.

Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.

Groll AH, Lyman CA, Petraitis V, Petraitiene R, Armstrong D, Mickiene D, Alfaro RM, Schaufele RL, Sein T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2006 Oct;50(10):3418-23.

47.

Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.

Meletiadis J, Petraitis V, Petraitiene R, Lin P, Stergiopoulou T, Kelaher AM, Sein T, Schaufele RL, Bacher J, Walsh TJ.

J Infect Dis. 2006 Oct 1;194(7):1008-18. Epub 2006 Aug 28.

PMID:
16960790
48.
49.

Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.

Petraitis V, Petraitiene R, Solomon J, Kelaher AM, Murray HA, Mya-San C, Bhandary AK, Sein T, Avila NA, Basevicius A, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2006 Apr;50(4):1510-7.

50.

Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis.

Kasai M, Francesconi A, Petraitiene R, Petraitis V, Kelaher AM, Kim HS, Meletiadis J, Sein T, Bacher J, Walsh TJ.

J Clin Microbiol. 2006 Jan;44(1):143-50.

Supplemental Content

Loading ...
Support Center